407 related articles for article (PubMed ID: 35682991)
1. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; D'Angelo L; Santoro A; Nuti M; Rahimi H; Rughetti A
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682991
[TBL] [Abstract][Full Text] [Related]
2. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
3. Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma.
Videla-Richardson GA; Morris-Hanon O; Torres NI; Esquivel MI; Vera MB; Ripari LB; Croci DO; Sevlever GE; Rabinovich GA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008740
[TBL] [Abstract][Full Text] [Related]
4. Glycan-Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them.
Kremsreiter SM; Kroell AH; Weinberger K; Boehm H
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638920
[TBL] [Abstract][Full Text] [Related]
5. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
[TBL] [Abstract][Full Text] [Related]
6. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways.
Rabinovich GA; Conejo-García JR
J Mol Biol; 2016 Aug; 428(16):3266-3281. PubMed ID: 27038510
[TBL] [Abstract][Full Text] [Related]
7. Glioblastomas exploit truncated O
Dusoswa SA; Verhoeff J; Abels E; Méndez-Huergo SP; Croci DO; Kuijper LH; de Miguel E; Wouters VMCJ; Best MG; Rodriguez E; Cornelissen LAM; van Vliet SJ; Wesseling P; Breakefield XO; Noske DP; Würdinger T; Broekman MLD; Rabinovich GA; van Kooyk Y; Garcia-Vallejo JJ
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3693-3703. PubMed ID: 32019882
[TBL] [Abstract][Full Text] [Related]
8. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
Salatino M; Rabinovich GA
Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
[TBL] [Abstract][Full Text] [Related]
9. Re-wiring regulatory cell networks in immunity by galectin-glycan interactions.
Blidner AG; Méndez-Huergo SP; Cagnoni AJ; Rabinovich GA
FEBS Lett; 2015 Nov; 589(22):3407-18. PubMed ID: 26352298
[TBL] [Abstract][Full Text] [Related]
10. Implications of altered O-glycosylation in tumour immune evasion.
Itano N
J Biochem; 2019 May; 165(5):387-390. PubMed ID: 30649348
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins.
Bax M; García-Vallejo JJ; Jang-Lee J; North SJ; Gilmartin TJ; Hernández G; Crocker PR; Leffler H; Head SR; Haslam SM; Dell A; van Kooyk Y
J Immunol; 2007 Dec; 179(12):8216-24. PubMed ID: 18056365
[TBL] [Abstract][Full Text] [Related]
12. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation.
Mendez-Huergo SP; Maller SM; Farez MF; Mariño K; Correale J; Rabinovich GA
Cytokine Growth Factor Rev; 2014 Jun; 25(3):247-55. PubMed ID: 24684768
[TBL] [Abstract][Full Text] [Related]
13. The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2).
da Costa V; van Vliet SJ; Carasi P; Frigerio S; García PA; Croci DO; Festari MF; Costa M; Landeira M; Rodríguez-Zraquia SA; Cagnoni AJ; Cutine AM; Rabinovich GA; Osinaga E; Mariño KV; Freire T
Cancer Lett; 2021 Oct; 518():72-81. PubMed ID: 34144098
[TBL] [Abstract][Full Text] [Related]
14. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
15. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.
Pinho SS; Alves I; Gaifem J; Rabinovich GA
Cell Mol Immunol; 2023 Oct; 20(10):1101-1113. PubMed ID: 37582971
[TBL] [Abstract][Full Text] [Related]
16. Rho GTPase Rac1: molecular switch within the galectin network and for N-glycan α2,6-sialylation/O-glycan core 1 sialylation in colon cancer in vitro.
André S; Singh T; Lacal JC; Smetana K; Gabius HJ
Folia Biol (Praha); 2014; 60(3):95-107. PubMed ID: 25056432
[TBL] [Abstract][Full Text] [Related]
17. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
Shu L; Lin S; Zhou S; Yuan T
Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
[TBL] [Abstract][Full Text] [Related]
18. Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy.
Gupta B; Sadaria D; Warrier VU; Kirtonia A; Kant R; Awasthi A; Baligar P; Pal JK; Yuba E; Sethi G; Garg M; Gupta RK
Semin Cancer Biol; 2022 May; 80():87-106. PubMed ID: 32068087
[TBL] [Abstract][Full Text] [Related]
19. Altered tumor-cell glycosylation promotes metastasis.
Häuselmann I; Borsig L
Front Oncol; 2014; 4():28. PubMed ID: 24592356
[TBL] [Abstract][Full Text] [Related]
20. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment.
Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA
Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
